IRIDEX Valuation
| IRIX Stock | USD 1.77 0.12 6.35% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. IRIDEX retains a regular Real Value of $2.22 per share. The prevalent price of the firm is $1.77. Our model calculates the value of IRIDEX from analyzing the firm fundamentals such as Operating Margin of (0.16) %, return on equity of -1.5, and Return On Asset of -0.21 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting IRIDEX's valuation include:
Price Book 7.4053 | Enterprise Value 29.6 M | Enterprise Value Ebitda (3.61) | Price Sales 0.608 | Enterprise Value Revenue 0.596 |
Undervalued
Today
Please note that IRIDEX's price fluctuation is very risky at this time. Calculation of the real value of IRIDEX is based on 3 months time horizon. Increasing IRIDEX's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since IRIDEX is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IRIDEX Stock. However, IRIDEX's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.77 | Real 2.22 | Target 3.88 | Hype 1.77 | Naive 1.71 |
The intrinsic value of IRIDEX's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence IRIDEX's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of IRIDEX helps investors to forecast how IRIDEX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IRIDEX more accurately as focusing exclusively on IRIDEX's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use IRIDEX's intrinsic value based on its ongoing forecasts of IRIDEX's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against IRIDEX's closest peers.
IRIDEX Cash |
|
IRIDEX Valuation Trend
Analysing the historical paterns of IRIDEX's enterprise value and its market capitalization is a good way to estimate and gauge the value of IRIDEX over time and is usually enough for investors to make rational market timing decisions.
IRIDEX Total Value Analysis
IRIDEX is currently forecasted to have valuation of 29.62 M with market capitalization of 29.45 M, debt of 2.75 M, and cash on hands of 17.97 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the IRIDEX fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
29.62 M | 29.45 M | 2.75 M | 17.97 M |
IRIDEX Investor Information
About 21.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.67. IRIDEX last dividend was issued on the 30th of September 2010. Based on the key measurements obtained from IRIDEX's financial statements, IRIDEX is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.IRIDEX Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. IRIDEX has an asset utilization ratio of 150.62 percent. This suggests that the Company is making $1.51 for each dollar of assets. An increasing asset utilization means that IRIDEX is more efficient with each dollar of assets it utilizes for everyday operations.IRIDEX Ownership Allocation
IRIDEX has a total of 16.64 Million outstanding shares. IRIDEX secures noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.IRIDEX Profitability Analysis
The company reported the previous year's revenue of 51.87 M. Net Loss for the year was (9.57 M) with profit before overhead, payroll, taxes, and interest of 25.37 M.About IRIDEX Valuation
Our relative valuation model uses a comparative analysis of IRIDEX. We calculate exposure to IRIDEX's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of IRIDEX's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 21.8 M | 19 M | |
| Pretax Profit Margin | (0.15) | (0.14) | |
| Operating Profit Margin | (0.15) | (0.14) | |
| Net Loss | (0.15) | (0.14) | |
| Gross Profit Margin | 0.51 | 0.54 |
IRIDEX Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 16.1 M |
IRIDEX Current Valuation Indicators
Valuation refers to the process of determining the present value of IRIDEX and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value IRIDEX we look at many different elements of the entity such as IRIDEX's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as IRIDEX, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use IRIDEX's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes IRIDEX's worth.Additional Tools for IRIDEX Stock Analysis
When running IRIDEX's price analysis, check to measure IRIDEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRIDEX is operating at the current time. Most of IRIDEX's value examination focuses on studying past and present price action to predict the probability of IRIDEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRIDEX's price. Additionally, you may evaluate how the addition of IRIDEX to your portfolios can decrease your overall portfolio volatility.